Vertex (VRTX) CMO Dr. Carmen Bozic Sells 596 Shares

What Happened

• Dr. Carmen Bozic, EVP and Chief Medical Officer of Vertex Pharmaceuticals (VRTX), disposed of 596 shares in a sale on June 26, 2026. The shares were sold at $482.50 per share for a total transaction value of $287,570. This was a sale (not a purchase) and therefore is not a direct bullish signal; it was executed under a pre-established plan.

Key Details

• Transaction date: 2026-06-26
• Transaction type/code: Sale (S) — open market or private sale
• Price per share: $482.50
• Shares sold: 596
• Total value: $287,570
• Footnote: Transaction made pursuant to Dr. Bozic’s company‑approved Rule 10b5-1 trading plan entered on 2025-11-20
• Shares owned after the transaction: Not specified in the provided Form 4 excerpt
• Filing timeliness: Report filed 2026-06-30; filing appears to be within the typical Form 4 deadline (filed the next business day window)

Context

• The sale was executed under a Rule 10b5-1 trading plan, which allows insiders to sell shares according to a preset schedule and generally indicates the transaction was planned in advance rather than reactive to recent company news. Sales under 10b5-1 plans are common and do not necessarily reflect the insider’s current view of the company.